Ongoing Phase II Pancreatic Cancer Trial Metabolic therapy is tumor-treating, patient-sparing

Jon Eckard, MD, TYME Inc., explains Ongoing Phase II Pancreatic Cancer Trial Metabolic therapy is tumor-treating, patient-sparing at ASCO 2018. Author: Annual-Meeting Added: 06/06/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts